Covered recipient · General Payments record
TAMI J GRIFFITH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,979.77
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $318.76 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $90.36 | 4 |
| GlaxoSmithKline, LLC. | $46.92 | 2 |
| Acerta Pharma LLC | $36.74 | 2 |
| Lilly USA, LLC | $31.77 | 2 |
| Astellas Pharma US Inc | $25.86 | 1 |
| Amgen Inc. | $21.01 | 1 |
| DEXCOM, INC. | $19.67 | 1 |
| PFIZER INC. | $18.33 | 1 |
| Novo Nordisk AS | $14.36 | 1 |
| Exact Sciences Corporation | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.85 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107255990 | CMS |
| ABBVIE INC. | $14.02 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107255992 | CMS |
| ABBVIE INC. | $28.65 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107255994 | CMS |
| ABBVIE INC. | $25.84 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107255996 | CMS |
| Amgen Inc. | $21.01 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117266627 | CMS |
| Astellas Pharma US Inc | $25.86 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139550493 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.57 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104757212 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.17 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104736107 | CMS |
| Dexcom, Inc. | $19.67 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388741 | CMS |
| Exact Sciences Corporation | $13.74 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114469965 | CMS |
| GlaxoSmithKline, LLC. | $24.33 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116383898 | CMS |
| GlaxoSmithKline, LLC. | $22.59 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116327590 | CMS |
| Lilly USA, LLC | $15.93 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135958937 | CMS |
| Lilly USA, LLC | $15.84 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920382 | CMS |
| Novo Nordisk Inc | $14.36 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100651957 | CMS |
| PFIZER INC. | $18.33 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131185862 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.